In cisplatin-induced AKI, the anti-TIM-1 antibody RMT1–10 showed protective effects by ameliorating renal histological damage and dysfunction, reducing apoptosis, and inhibiting leukocyte recruitment and inflammatory injury [87]. The gene discussed is HAVCR1; the disease is acute kidney injury.